Article

Steinbrenner, ICAD 2010, and More Alzheimer's in the News

The death of the Yankees long-time owner one of several recent Alzheimer's-related stories making headlines.

Yankees Owner Dies at 80 — George Steinbrenner, who purchased the team in 1973 and had been suffering from a number of confirmed and assumed illnesses (including Alzheimer’s disease), died after suffering a massive heart attack at his home in Tampa, FL early this morning.

International Conference on Alzheimer’s Disease 2010 — The annual meeting runs through July 15th and has featured presentations on the link between race and Alzheimer’s progression and severity; the launch of the new Alzheimer’s Association’s “Research Center” website, designed to increase the public’s knowledge of Alzheimer’s; and the start of TrialMatch, the Alzheimer’s Association’s new confidential, free tool that provides comprehensive clinical trial information and an individualized trial matching service through phone- and Internet-based service.

Gene Linked to Obesity May Also Raise Dementia Risk — Researchers from the Karolinska Institute in Sweden have discovered that a variant of the obesity-related gene FTO may also increase an individual’s risk for Alzheimer’s disease and dementia, a risk that could be further increased for individuals with the FTO-AA variant and a gene mutation, APOE4, the highest-risk variant of the known Alzheimer's-related gene called APOE.

Low Levels of Vitamin D Linked with Cognitive Decline, Alzheimer’s — Older men and women with low levels of vitamin D “were 60 percent more likely to have substantial cognitive decline during the six year follow-up and 30 percent more likely to have declines on the test measuring executive function than those with sufficient levels,” according to new research from the University of Exeter in England.

Related Videos
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Akif Shameem, MD: Generalized Anxiety Disorder Linked to Longer Hospitals in Children with IBD
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
© 2024 MJH Life Sciences

All rights reserved.